Skip to content

Clinical trials

Uveitis, Posterior trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uveitis, Posterior Country / region: United States Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20065
20073
20082
20092
20104
20111
20122
20132
20144
20151
20161
20175
20181
20211
20225
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated12
Unknown status4
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clearside Biomedical, Inc.5
Novartis Pharmaceuticals5
National Eye Institute (NEI)3
XOMA (US) LLC3
Allergan2
Johns Hopkins University2
Lux Biosciences, Inc.2
Novartis2
Texas Retina Associates2
ACELYRIN Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uveitis, Posterior41
Uveitis32
Uveitis, Intermediate32
Panuveitis22
Uveitis, Anterior8
Macular Edema4
Behcet Syndrome2
Choroidal Effusions2
Inflammation2
Ophthalmia, Sympathetic2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.